• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACAP3 通过 HDAC2 负调控抑制甲状腺乳头状癌细胞的恶性发展。

ACAP3 negatively regulated by HDAC2 inhibits the malignant development of papillary thyroid carcinoma cells.

机构信息

Endocrinology department, The Second Affiliated Hospital Zhejiang University School of Medicine, China; Endocrinology department, Sanmen People's Hospital, China.

Pathology department, Sanmen People's Hospital, China.

出版信息

Int J Biochem Cell Biol. 2024 Sep;174:106635. doi: 10.1016/j.biocel.2024.106635. Epub 2024 Aug 3.

DOI:10.1016/j.biocel.2024.106635
PMID:39098591
Abstract

ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 (ACAP3) level has been confirmed to be downregulated in papillary thyroid carcinoma (PTC). Histone deacetylase inhibitors (HDACIs) have therapeutic effects on PTC. Accordingly, this study probed into the potential relation of histone deacetylase 2 (HDAC2) and ACAP3 in PTC. Expressions of ACAP3 and HDAC2 in PTC were investigated by quantitative real-time polymerase chain reaction (qRT-PCR). The relationship between HDAC2 and ACAP3 was predicted by Pearson analysis. Cell functional assays (cell counting kit-8, transwell, wound healing and flow cytometry assays) and rescue assay were carried out to determine the effects of HDAC2/ACAP3 axis on biological behaviors of PTC cells. Expressions of apoptosis-, epithelial-mesenchymal transition-, Protein Kinase B (AKT)-, and P53-related proteins were measured by Western blot. ACAP3 level was downregulated in PTC tissues and cells. ACAP3 overexpression (oe-ACAP3) suppressed viability, proliferation, migration and invasion of PTC cells, facilitated apoptosis, downregulated the expressions of Protein Kinase B (Bcl-2) and N-cadherin, upregulated the expressions of Bcl-2 associated protein X (Bax) and E-cadherin, diminished the p-AKT/AKT ratio and elevated the p-p53/p53 ratio; however, ACAP3 silencing or HDAC2 overexpression (oe-HDAC2) did the opposite. HDAC2 negatively correlated with ACAP3. The tumor-suppressing effect of oe-ACAP3 in PTC was reversed by oe-HDAC2. Collectively, ACAP3 negatively regulated by HDAC2 suppresses the proliferation and metastasis while facilitating apoptosis of PTC cells.

摘要

ArfGAP 与卷曲螺旋、锚重复和 PH 结构域 3(ACAP3)的水平已被证实在甲状腺乳头状癌(PTC)中下调。组蛋白去乙酰化酶抑制剂(HDACIs)对 PTC 具有治疗作用。因此,本研究探讨了 PTC 中组蛋白去乙酰化酶 2(HDAC2)和 ACAP3 之间的潜在关系。通过实时定量聚合酶链反应(qRT-PCR)研究 PTC 中 ACAP3 和 HDAC2 的表达。通过 Pearson 分析预测 HDAC2 和 ACAP3 之间的关系。进行细胞功能测定(细胞计数试剂盒-8、Transwell、划痕愈合和流式细胞术测定)和挽救测定,以确定 HDAC2/ACAP3 轴对 PTC 细胞生物学行为的影响。通过 Western blot 测定凋亡、上皮-间充质转化、蛋白激酶 B(AKT)和 P53 相关蛋白的表达。ACAP3 在 PTC 组织和细胞中表达下调。ACAP3 过表达(oe-ACAP3)抑制 PTC 细胞的活力、增殖、迁移和侵袭,促进凋亡,下调蛋白激酶 B(Bcl-2)和 N-钙粘蛋白的表达,上调 Bcl-2 相关蛋白 X(Bax)和 E-钙粘蛋白的表达,降低 p-AKT/AKT 比值,升高 p-p53/p53 比值;然而,ACAP3 沉默或 HDAC2 过表达(oe-HDAC2)则相反。HDAC2 与 ACAP3 呈负相关。oe-ACAP3 在 PTC 中的肿瘤抑制作用被 oe-HDAC2 逆转。综上所述,ACAP3 受 HDAC2 的负调控,抑制 PTC 细胞的增殖和转移,同时促进凋亡。

相似文献

1
ACAP3 negatively regulated by HDAC2 inhibits the malignant development of papillary thyroid carcinoma cells.ACAP3 通过 HDAC2 负调控抑制甲状腺乳头状癌细胞的恶性发展。
Int J Biochem Cell Biol. 2024 Sep;174:106635. doi: 10.1016/j.biocel.2024.106635. Epub 2024 Aug 3.
2
Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.沉默长链非编码 RNA 烟酰胺核苷酸转氢酶反义 RNA 1 通过靶向 miR-199a-5p 抑制甲状腺乳头状癌细胞增殖、迁移和侵袭并促进细胞凋亡。
Endocr J. 2021 May 28;68(5):583-597. doi: 10.1507/endocrj.EJ20-0353. Epub 2021 Mar 20.
3
Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.沉默 SIX1 通过调控 TGF-β/Smad2/3 信号通路抑制甲状腺乳头状癌细胞上皮间质转化。
Auris Nasus Larynx. 2021 Jun;48(3):487-495. doi: 10.1016/j.anl.2020.10.002. Epub 2020 Oct 17.
4
LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis.LncRNA-HCG18 通过调控 miR-106a-5p/PPP2R2A 轴调节甲状腺乳头状癌细胞的活力、凋亡、迁移、侵袭和上皮间质转化。
Pathol Res Pract. 2021 May;221:153395. doi: 10.1016/j.prp.2021.153395. Epub 2021 Mar 4.
5
MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.miR-192-5p 通过调控 SH3RF3 抑制甲状腺乳头状癌细胞的增殖、迁移和侵袭。
Biosci Rep. 2021 Sep 30;41(9). doi: 10.1042/BSR20210342.
6
LncRNA CASC9 facilitates papillary thyroid cancer development and doxorubicin resistance via miR-28-3p/BCL-2 axis and PI3K/AKT signaling pathway.长链非编码 RNA CASC9 通过 miR-28-3p/BCL-2 轴和 PI3K/AKT 信号通路促进甲状腺乳头状癌细胞的发展和多柔比星耐药性。
J Cardiothorac Surg. 2024 Nov 13;19(1):629. doi: 10.1186/s13019-024-03129-4.
7
MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.微小 RNA-26a 通过靶向 ROCK1 并调控 PI3K/AKT 信号通路抑制甲状腺乳头状癌细胞的恶性生物学行为。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8940-8949. doi: 10.26355/eurrev_201910_19292.
8
KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.KCNIP3 沉默通过激活 Wnt/β-catenin 通路促进甲状腺乳头状癌的增殖和上皮-间充质转化。
Tissue Cell. 2022 Apr;75:101739. doi: 10.1016/j.tice.2022.101739. Epub 2022 Jan 14.
9
Regulates -Induced EMT Gene Transcription to Promote the Metastasis and Tumorigenesis of Papillary Thyroid Carcinoma.调控诱导 EMT 基因转录促进甲状腺乳头状癌的转移和肿瘤发生。
Discov Med. 2024 Sep;36(188):1819-1830. doi: 10.24976/Discov.Med.202436188.168.
10
TMEM252 inhibits epithelial-mesenchymal transition and progression in papillary thyroid carcinoma by regulating Notch1 expression.跨膜蛋白252通过调节Notch1表达抑制甲状腺乳头状癌的上皮-间质转化及进展。
Head Neck. 2025 Jan;47(1):324-338. doi: 10.1002/hed.27922. Epub 2024 Aug 16.